GSK logo linking to the homepage Menu Behind the science Unlocking the secrets of the immune system Herpes zoster virus of shingles Press releases 21 October 2018 GSK presents new efficacy and safety data of an anti GM-CSF antibody in patients with rheumatoid arthritis 18 October 2018 ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV 02 October 2018 GSK updates policy for working with healthcare professionals View all press releases London 1,557.60 +47.00 Share price at 17:07 LSE price updated every 15 minutes. Timezone BST NYSE 40.87 +1.26 Share price at 16:02 NYSE price updated every 20 minutes. Timezone EST Tweets from GSK GSK @GSK #NEWS Rheumatoid arthritis still impacts 24.5 million people globally. Through our immunology research we are working to discover and develop new treatments to address this challenge. Read more in our press release gsk.to/2q3R2p6 about 11 hours ago GSK @GSK A functioning immune system is crucial to our health. If it goes awry, it can lead to many diseases. That’s why #immunology is at the heart of our new approach to R&D: gsk.to/2NQIyLj #ACR18 about 1 day ago GSK @GSK What’s the difference between pandemic and seasonal flu? @ThomasBreuer_MD, our Chief Vaccines Medic, shares some #flufacts #vaccinateforlife about 1 day ago Follow us on Twitter Find out more Our products We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them Health for all Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world. GSK Quick links Behind the science About us Products Careers Investors Media Research Responsibility Legal Terms of use Cookie policy Privacy Notice Modern Slavery Act statement 2017 PDF - 199.6KB Accessibility Sitemap Accessibility Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business © 2001-2018 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.